CA-170 [CAS 1673534-76-3]
Partner: MedChemexpress LLC
CAS No: | 1673534-76-3 |
Applications: | COVID-19-immunoregulation |
MW: | 360.32 |
Formula: | C12H20N6O7 |
SMILES: | C[C@@H](O)[C@@H](C(O)=O)NC(N[C@H](C1=NC([C@@H](N)CO)=NO1)CC(N)=O)=O |
Purity: | 99.39 |
Description: | CA-170 is an orally delivered dual inhibitor of VISTA and PD-L1. CA-170 exhibits potent rescue of proliferation and effector functions of T cells inhibited by PD-L1/L2 and VISTA with selectivity over other immune checkpoint proteins as well as a broad panel of receptors and enzymes[1][2]. |
Shipping Conditions: | Ship at ambient |
Usage: | Research Use Only |
Insight Biotechnology Ltd reserves the right to change pricing without notice